Literature DB >> 25482542

Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody.

Yael Udi1, Moran Grossman1, Inna Solomonov1, Orly Dym2, Haim Rozenberg2, Vanessa Moreno3, Philippe Cuniasse4, Vincent Dive4, Alicia García Arroyo3, Irit Sagi5.   

Abstract

Membrane type 1 metalloprotease (MT1-MMP) is a membrane-anchored, zinc-dependent protease. MT1-MMP is an important mediator of cell migration and invasion, and overexpression of this enzyme has been correlated with the malignancy of various tumor types. Therefore, modulators of MT1-MMP activity are proposed to possess therapeutic potential in numerous invasive diseases. Here we report the inhibition mode of MT1-MMP by LEM-2/15 antibody, which targets a surface epitope of MT1-MMP. Specifically, the crystal structures of Fab LEM-2/15 in complex with the MT1-MMP surface antigen suggest that conformational swiveling of the enzyme surface loop is required for effective binding and consequent inhibition of MT1-MMP activity on the cell membrane. This inhibition mechanism appears to be effective in controlling active MT1-MMP in endothelial cells and at the leading edge of migratory cancer cells.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25482542     DOI: 10.1016/j.str.2014.10.012

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  24 in total

1.  Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.

Authors:  Valeria Arkadash; Gal Yosef; Jason Shirian; Itay Cohen; Yuval Horev; Moran Grossman; Irit Sagi; Evette S Radisky; Julia M Shifman; Niv Papo
Journal:  J Biol Chem       Date:  2017-01-13       Impact factor: 5.157

2.  The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo- and radiotherapy responses of breast cancer.

Authors:  Varsha Thakur; Keman Zhang; Alyssa Savadelis; Patrick Zmina; Brittany Aguila; Scott M Welford; Fadi Abdul-Karim; Kristen W Bonk; Ruth A Keri; Barbara Bedogni
Journal:  Cancer Lett       Date:  2018-11-29       Impact factor: 8.679

Review 3.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

4.  Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.

Authors:  Tyler Lopez; Dong Hyun Nam; Evan Kaihara; Zahid Mustafa; Xin Ge
Journal:  Biotechnol Bioeng       Date:  2017-02-20       Impact factor: 4.530

5.  Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

Authors:  Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Lillian Onwuha-Ekpete; Kelli Harmon; Trista Robichaud; Rita Fuerst; Roma Stawikowska; Bjorn Steffensen; William Roush; Hector R Wong; Gregg B Fields
Journal:  J Med Chem       Date:  2017-04-19       Impact factor: 7.446

6.  Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity.

Authors:  Moustafa Sakr; Xiao-Yan Li; Farideh Sabeh; Tamar Y Feinberg; John J G Tesmer; Yi Tang; Stephen J Weiss
Journal:  J Biol Chem       Date:  2018-04-11       Impact factor: 5.157

7.  Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.

Authors:  Tyler Lopez; Chen Chuan; Aaron Ramirez; Kuan-Hui E Chen; Mary Y Lorenson; Chris Benitez; Zahid Mustafa; Henry Pham; Ramon Sanchez; Ameae M Walker; Xin Ge
Journal:  Biotechnol Bioeng       Date:  2018-09-15       Impact factor: 4.530

8.  Protease Inhibition Mechanism of Camelid-like Synthetic Human Antibodies.

Authors:  Dong Hyun Nam; Ki Baek Lee; Evan Kruchowy; Henry Pham; Xin Ge
Journal:  Biochemistry       Date:  2020-09-30       Impact factor: 3.162

Review 9.  Monoclonal antibodies against metzincin targets.

Authors:  Salvatore Santamaria; Rens de Groot
Journal:  Br J Pharmacol       Date:  2018-04-02       Impact factor: 8.739

10.  Generation of highly selective monoclonal antibodies inhibiting a recalcitrant protease using decoy designs.

Authors:  Ki Baek Lee; Zachary S Dunn; Tyler Lopez; Zahid Mustafa; Xin Ge
Journal:  Biotechnol Bioeng       Date:  2020-08-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.